Oral contraceptives and cancer.
Syntex Laboratories, Inc., Palo Alto, California.
R A
RA
Edgren
D000293:Adolescent; D000328:Adult; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000453:epidemiology; D003276:Contraceptives, Oral; D016889:Endometrial Neoplasms / Q000517:prevention & control; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced; D008545:Melanoma / Q000139:chemically induced / Q000453:epidemiology; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*; D016017:Odds Ratio; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D012306:Risk; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000453:epidemiology
D003276:Contraceptives, Oral